DECISION OF THE EEA JOINT COMMITTEE No 92/2024

of 26 April 2024

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/1912]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:

(1) Commission Regulation (EU) 2023/1464 of 14 July 2023 amending Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council as regards formaldehyde and formaldehyde releasers ( 1 ) is to be incorporated into the EEA Agreement.

(2) Commission Implementing Decision (EU) 2023/1155 of 9 June 2023 on the unresolved objections regarding the terms and conditions of the authorisation of the biocidal product Rapid Pro referred by France in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( 2 ) is to be incorporated into the EEA Agreement.

(3) Commission Implementing Decision (EU) 2023/1157 of 9 June 2023 on the unresolved objections regarding the terms and conditions of the authorisation of the biocidal product Virazan referred by France in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( 3 ) is to be incorporated into the EEA Agreement.

(4) Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

Chapter XV of Annex II to the EEA Agreement shall be amended as follows:

The following indent is added in point 12zc (Regulation (EC) No 1907/2006 of the European Parliament and of the Council):

‘—

32023 R 1464 : Commission Regulation (EU) 2023/1464 of 14 July 2023 ( OJ L 180, 17.7.2023, p. 12 ).’

The following points are added after point 12zzzzzzzzzze (Commission Implementing Regulation (EU) 2023/1530):

‘12zzzzzzzzzzf.

32023 D 1155 : Commission Implementing Decision (EU) 2023/1155 of 9 June 2023 on the unresolved objections regarding the terms and conditions of the authorisation of the biocidal product Rapid Pro referred by France in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 152, 13.6.2023, p. 13 ).

12zzzzzzzzzzg.

32023 D 1157 : Commission Implementing Decision (EU) 2023/1157 of 9 June 2023 on the unresolved objections regarding the terms and conditions of the authorisation of the biocidal product Virazan referred by France in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 152, 13.6.2023, p. 21 ).’

Article 2

The texts of Regulation (EU) 2023/1464 and Implementing Decisions (EU) 2023/1155 and (EU) 2023/1157 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union , shall be authentic.

Article 3

This Decision shall enter into force on 27 April 2024, provided that all the notifications under Article 103(1) of the EEA Agreement have been made ( *1 ) .

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union .

Done at Brussels, 26 April 2024.

For the EEA Joint Committee

The President

Nicolas VON LINGEN

( 1 ) OJ L 180, 17.7.2023, p. 12 .

( 2 ) OJ L 152, 13.6.2023, p. 13 .

( 3 ) OJ L 152, 13.6.2023, p. 21 .

( *1 ) No constitutional requirements indicated.

ELI: http://data.europa.eu/eli/dec/2024/1912/oj

ISSN 1977-0677 (electronic edition)